Author

G. Evan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Amirthanayagam· 1 shared A. Piskorz· 1 shared B. Basu· 1 shared B. Davies· 1 shared C. Caldas· 1 shared C. Sauer· 1 shared C. Swanton· 1 shared D. Calado· 1 shared

Activity by Year

2017-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Amirthanayagam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Somatic chromosomal number alterations affecting driver genes inform in-vitro and clinical drug response in high-grade serous ovarian cancer

F. Correia Martins, D.-L. Couturier, I. Santiago, C. Sauer, M. Vias, M. Angelova, D. Sanders, A. Piskorz, J. Hall, K. Hosking, A. Amirthanayagam, S. Cosulich, L. Carnevalli, B. Davies, T. B. K. Watkins, , J. D. Brenton

This study shows that somatic copy number alterations in driver genes correlate with drug response in HGSOC spheroid models and clinical settings.

bioRxiv · Oct 4, 2020 · PreprintCancer Biology

BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous cell carcinoma

K. A. Lazarus, F. Hadi, E. Zambon, K. Bach, M.-F. Santolla, J. K. Watson, L. L. Correia, M. Das, R. Ugur, S. Pensa, L. Becker, L. S. Campos, G. Ladds, P. Liu, G. Evan, , W. T. Khaled

This study identifies BCL11A as an oncogene in lung squamous cell carcinoma, showing its interaction with SOX2 to regulate epigenetic factors and demonstrating potential therapeutic targets.

bioRxiv · Nov 22, 2017Cancer Biology